Literature DB >> 19939363

The efficiency of progesterone vaginal gel versus intramuscular progesterone for luteal phase supplementation in gonadotropin-releasing hormone antagonist cycles: a prospective clinical trial.

Semra Kahraman1, S Hale Karagozoglu, Guvenc Karlikaya.   

Abstract

We compared the efficiency of progesterone vaginal gel (PVG) with intramuscular progesterone (IMP) supplementation for luteal phase support after in vitro fertilization and embryo transfer in gonadotropin-releasing hormone (GnRH) antagonist cycles. The treatment outcomes were similar for PVG and IMP for luteal support in GnRH-antagonist protocols. With its ease of use, high tolerability by patients, and fewer side effects, PVG can be a successful alternative to IMP. Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19939363     DOI： 10.1016/j.fertnstert.2009.10.004

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  12 in total

1.  Comparison of daily vaginal progesterone gel plus weekly intramuscular progesterone with daily intramuscular progesterone for luteal phase support in single, autologous euploid frozen-thawed embryo transfers.

Authors:  Mehmet Resit Asoglu; Cem Celik; Lale Susan Karakis; Necati Findikli; Meral Gultomruk; Mustafa Bahceci
Journal:  J Assist Reprod Genet       Date:  2019-05-18       Impact factor: 3.412

Review 2.  Luteal phase support for assisted reproduction cycles.

Authors:  Michelle van der Linden; Karen Buckingham; Cindy Farquhar; Jan A M Kremer; Mostafa Metwally
Journal:  Cochrane Database Syst Rev       Date:  2015-07-07

3.  Patients' administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support.

Authors:  Angeline N Beltsos; Mark D Sanchez; Kevin J Doody; Mark R Bush; Alice D Domar; Michael G Collins
Journal:  Reprod Health       Date:  2014-11-11       Impact factor: 3.223

4.  Comparing intramuscular progesterone, vaginal progesterone and 17 -hydroxyprogestrone caproate in IVF and ICSI cycle.

Authors:  Ashraf Moini; Fatemeh Zafarani; Bita Eslami; Maria Sadeghi; Zahra Kamyabi; Nadia Jahangiri
Journal:  Iran J Reprod Med       Date:  2011

5.  Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts.

Authors:  Daniel B Shapiro; Jennifer A Pappadakis; Nancy M Ellsworth; Howard I Hait; Zsolt Peter Nagy
Journal:  Hum Reprod       Date:  2014-05-20       Impact factor: 6.918

6.  Comparison of Vaginal Gel and Intramuscular Progesterone for In vitro Fertilization and Embryo Transfer with Gonadotropin-Releasing Hormone Antagonist Protocol.

Authors:  Hong-Bin Chi; Na-Na Liu; Rong Li; Li-Yuan Tao; Li-Xue Chen; Jie Qiao
Journal:  Chin Med J (Engl)       Date:  2018-07-05       Impact factor: 2.628

7.  Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study.

Authors:  Jennifer B Bakkensen; Catherine Racowsky; Ann M Thomas; Andrea Lanes; Mark D Hornstein
Journal:  Fertil Res Pract       Date:  2020-07-01

8.  Low dose hCG supplementation in a Gn-RH-agonist trigger protocol is associated with worse pregnancy outcomes: a retrospective cohort study.

Authors:  Maren Shapiro; Phillip Romanski; Ann Thomas; Andrea Lanes; Elena Yanushpolsky
Journal:  Fertil Res Pract       Date:  2021-05-28

9.  Crinone Gel for Luteal Phase Support in Frozen-Thawed Embryo Transfer Cycles: A Prospective Randomized Clinical Trial in the Chinese Population.

Authors:  Yang Wang; Yaqiong He; Xiaoming Zhao; Xiaowei Ji; Yan Hong; Yuan Wang; Qinling Zhu; Bin Xu; Yun Sun
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

10.  Intramuscular progesterone (Gestone) versus vaginal progesterone suppository (Cyclogest) for luteal phase support in cycles of in vitro fertilization-embryo transfer: patient preference and drug efficacy.

Authors:  Amal Yaseen Zaman; Serdar Coskun; Ahmed Abdullah Alsanie; Khalid Arab Awartani
Journal:  Fertil Res Pract       Date:  2017-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.